Drug Patent Reform’s Often Been Postponed, Is Congress Ready To Act?

Written by

David Mitchell, president and founder of Patients for Affordable Drugs, listens during a Senate … More Judiciary Committee hearing on the intellectual property and price of prescription drugs in Washington, D.C. Senator John Cornyn of Texas is leading a push to see if pharmaceutical companies are abusing federal laws to extend the life of their patents and fend off competition by generic drugmakers. Photographer: Melissa Lyttle/Bloomberg

The Senate Judiciary…

Continue Reading

News Source: www.forbes.com

Drug Patent Reform’s Often Been Postponed, Is Congress Ready To Act?

Continue Reading

Comments

Leave a Reply Cancel reply

More posts

Recall issued for breaded chicken after major allergen left off label

Dashcam footage captures moment couple tries to stop Bondi shooter | Gun Violence

Changing the paradigm on hypermobile Ehlers-Danlos Syndrome: Connective tissues don't tell the whole story

Improving the medical and forensic care of sexual assault survivors in the emergency department